Personal information

United States

Activities

Employment (4)

Alkermes (United States): Waltham, Massachusetts, US

2022-07-05 to present | Director, Head of Functional Genomics (Modeling and Informatics)
Employment
Source: Self-asserted source
Harikiran Nistala

GlaxoSmithKline: Cambridge, MA, US

2021-05-03 to present | Associate Director (Human Genetics and Computational Biology)
Employment
Source: Self-asserted source
Harikiran Nistala

Regeneron Genetics Center: Tarrytown, NY, US

2014-12-01 to 2021-04-01 | Senior Staff Scientist (Functional Genomics)
Employment
Source: Self-asserted source
Harikiran Nistala

Harvard Medical School: Boston, MA, US

2010-06-01 to 2014-11-25 | Research Fellow
Employment
Source: Self-asserted source
Harikiran Nistala

Education and qualifications (2)

Mount Sinai School of Medicine at New York University: New York, NY, US

2005-08-01 to 2010-06-01 | Doctor of Philosophy (Pharmacology and Systems Therapeutics)
Education
Source: Self-asserted source
Harikiran Nistala

Clemson University: Clemson, SC, US

2001-08-01 to 2003-06-30 | Master of Science (Bioengineering)
Education
Source: Self-asserted source
Harikiran Nistala

Professional activities (1)

International Bone and Mineral Society: Chicago, US

2012-10 | The Gideon and Sevgi Rodan Fellowship
Distinction
Source: Self-asserted source
Harikiran Nistala

Works (14)

NMIHBA results from hypomorphic PRUNE1 variants that lack short-chain exopolyphosphatase activity

Human Molecular Genetics
2021-01-06 | Journal article
Contributors: Harikiran Nistala; John Dronzek; Claudia Gonzaga-Jauregui; Shek Man Chim; Saathyaki Rajamani; Samer Nuwayhid; Dennis Delgado; Elizabeth Burke; Ender Karaca; Matthew C Franklin et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Genome-wide survey of parent-of-origin specific associations across clinical traits derived from electronic health records

medRxiv
2020 | Other
EID:

2-s2.0-85099888289

Contributors: Kim, H.I.; Ye, B.; Staples, J.; Marcketta, A.; Gao, C.; Shuldiner, A.R.; van Hout, C.V.; Adams, L.J.; Blank, J.; Bodian, D. et al.
Source: Self-asserted source
Harikiran Nistala via Scopus - Elsevier

Functional biology of the Steel syndrome founder allele and evidence for clan genomics derivation of COL27A1 pathogenic alleles worldwide

European Journal of Human Genetics
2020-09-06 | Journal article
Contributors: Claudia Gonzaga-Jauregui; Gozde Yesil; Harikiran Nistala; Alper Gezdirici; Yavuz Bayram; Kalyan C. Nannuru; Davut Pehlivan; Bo Yuan; Johanna Jimenez; Yavuz Sahin et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Functional modeling of NMIHBA-causing PRUNE1 variants reveals a requirement for its exopolyphosphatase activity

bioRxiv
2020-03-04 | Preprint
Source: Self-asserted source
Harikiran Nistala
grade
Preferred source (of 2)‎

Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome [Human Molecular Genetics (2010) 19,24, 4790-4798] DOI: 10.1093/hmg/ddq409

Human Molecular Genetics
2014 | Journal article
EID:

2-s2.0-84911413717

Part of ISSN: 14602083 09646906
Contributors: Nistala, H.; Lee-Arteaga, S.; Carta, L.; Cook, J.R.; Smaldone, S.; Siciliano, G.; Rifkin, A.N.; Dietz, H.C.; Rifkin, D.B.; Ramirez, F.
Source: Self-asserted source
Harikiran Nistala via Scopus - Elsevier

Caffey disease: new perspectives on old questions.

Bone
2013-12-31 | Journal article
Source: Self-asserted source
Harikiran Nistala
grade
Preferred source (of 2)‎

Generation of Fbn1 conditional null mice implicates the extracellular microfibrils in osteoprogenitor recruitment.

Genesis (New York, N.Y. : 2000)
2012-03-31 | Journal article
Source: Self-asserted source
Harikiran Nistala
grade
Preferred source (of 2)‎

Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome.

Human molecular genetics
2010-09-24 | Journal article
Source: Self-asserted source
Harikiran Nistala
grade
Preferred source (of 2)‎

Fibrillin-1 and -2 differentially modulate endogenous TGF-β and BMP bioavailability during bone formation.

The Journal of cell biology
2010-09-01 | Journal article
Source: Self-asserted source
Harikiran Nistala
grade
Preferred source (of 2)‎

Extracellular microfibrils control osteoblast-supported osteoclastogenesis by restricting TGF{beta} stimulation of RANKL production.

The Journal of biological chemistry
2010-08-21 | Journal article
Source: Self-asserted source
Harikiran Nistala
grade
Preferred source (of 2)‎

Drug-based therapies for vascular disease in Marfan syndrome: from mouse models to human patients.

The Mount Sinai journal of medicine, New York
2010-07-01 | Journal article
Source: Self-asserted source
Harikiran Nistala
grade
Preferred source (of 2)‎

Extracellular regulation of transforming growth factor beta and bone morphogenetic protein signaling in bone.

Annals of the New York Academy of Sciences
2010-03-01 | Journal article
Source: Self-asserted source
Harikiran Nistala
grade
Preferred source (of 2)‎

The mutation ROR2W749X, linked to human BDB, is a recessive mutation in the mouse, causing brachydactyly, mediating patterning of joints and modeling recessive Robinow syndrome.

Development (Cambridge, England)
2008-03-19 | Journal article
Source: Self-asserted source
Harikiran Nistala
grade
Preferred source (of 2)‎

Fibrillin-rich microfibrils - structural and instructive determinants of mammalian development and physiology.

Connective tissue research
2008-01-01 | Journal article
Source: Self-asserted source
Harikiran Nistala
grade
Preferred source (of 2)‎